Amylin oligomeric and plaque-like accumulations in brain parenchyma and cerebral vasculature were detected in T2D patients and in nondiabetic patients with late onset AD where amylin plaques were usually not co-localized with Aβ plaques. This evidence concerns the gene IAPP and Alzheimer disease.